Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany.

about

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.

P2860

Q50044569-8749D5A2-310A-4E5D-9B1A-F513D4C4B20E

P2860

Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany.

Item

http://www.wikidata.org/entity/Q38363108

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Trastuzumab in Esophagogastric ...... e Clinical Studies in Germany.

@en

type

Item

label

Trastuzumab in Esophagogastric ...... e Clinical Studies in Germany.

@en

prefLabel

Trastuzumab in Esophagogastric ...... e Clinical Studies in Germany.

@en

P1476

Trastuzumab in Esophagogastric ...... e Clinical Studies in Germany.

@en

P2093

Kirsten Merx

http://www.w3.org/2001/XMLSchema#string

Lenka Kellermann

http://www.w3.org/2001/XMLSchema#string

Manuel Barreto Miranda

http://www.w3.org/2001/XMLSchema#string

Michael Gonnermann

http://www.w3.org/2001/XMLSchema#string

Oliver Lange

http://www.w3.org/2001/XMLSchema#string

Ralf-Dieter Hofheinz

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

HER2 testing in gastric cancer: a practical approach

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Esophagogastric cancer: integration of targeted therapies into systemic chemotherapy.

The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).

Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.

Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.

P304

1028505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/1028505

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Ulrich Mahlknecht

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292206056

http://www.w3.org/2001/XMLSchema#string

P698

26941786

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

P932

4749805

http://www.w3.org/2001/XMLSchema#string

Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany.

about

P2860

P2860

Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932